Zenas BioPharma, Inc. (ZBIO) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Zenas BioPharma, Inc. (ZBIO): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 29/100 — a percentile rank of Zenas BioPharma, Inc.’s fundamentals against Manufacturing peers, weakest on growth. A quality ranking, not a price prediction.
| Market cap | $1.8B |
| P / S | 1757.8× |
| EV / EBITDA | -3.9× |
| Gross margin | 100.0% |
| Operating margin | -47557.3% |
| Net margin | -48438.4% |
| Return on equity | -196.0% |
| ROIC | -136.9% |
| Revenue growth | -93.3% |
| Debt / equity | 1.2× |
| Dividend yield | 0.0% |
Independent of the events above — derived from Zenas BioPharma, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact